Jan Korábečný

6.0k total citations
175 papers, 4.5k citations indexed

About

Jan Korábečný is a scholar working on Pharmacology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Jan Korábečný has authored 175 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Pharmacology, 65 papers in Computational Theory and Mathematics and 57 papers in Organic Chemistry. Recurrent topics in Jan Korábečný's work include Cholinesterase and Neurodegenerative Diseases (121 papers), Computational Drug Discovery Methods (65 papers) and Pesticide Exposure and Toxicity (36 papers). Jan Korábečný is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (121 papers), Computational Drug Discovery Methods (65 papers) and Pesticide Exposure and Toxicity (36 papers). Jan Korábečný collaborates with scholars based in Czechia, Serbia and United States. Jan Korábečný's co-authors include Kamil Kuča, Ondřej Soukup, Eugenie Nepovimová, Daniel Jun, Rafael Doležal, Lukáš Górecki, Katarína Špilovská, Vendula Šepsová, Kamil Musílek and Martin Andrš and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Jan Korábečný

169 papers receiving 4.5k citations

Peers

Jan Korábečný

PHARM

CTM

PHYSI

Ondřej Soukup Czechia

Bijo Mathew India

Marco Catto Italy

Michela Rosini Italy

Federica Belluti Italy

Ling Huang China

Angela Rampa Italy

Barbara Malawska Poland

Angelo Carotti Italy

Alessandra Bisi Italy

Ondřej Soukup Czechia

Jan Korábečný

2.2k ×0.8

PHARM

1.4k ×0.8

1.3k ×0.8

CTM

1.0k ×0.8

583 ×0.9

PHYSI

Citations per year, relative to Jan Korábečný Jan Korábečný (= 1×) peers Ondřej Soukup

Countries citing papers authored by Jan Korábečný

Since Specialization

Citations

This map shows the geographic impact of Jan Korábečný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Korábečný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Korábečný more than expected).

Fields of papers citing papers by Jan Korábečný

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Korábečný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Korábečný. The network helps show where Jan Korábečný may publish in the future.

Co-authorship network of co-authors of Jan Korábečný

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Korábečný. A scholar is included among the top collaborators of Jan Korábečný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Korábečný. Jan Korábečný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kassa, Jiřı́, Jan Konečný, Barbora Svobodová, et al.. (2025). Prophylaxis by a reversible cholinesterase inhibitor and the NMDA receptor antagonist treatment as combinatorial countermeasure against nerve agent poisoning in mice model. Chemico-Biological Interactions. 407. 111386–111386.

Mezeiová, Eva, Lukáš Prchal, Martina Hrabinová, et al.. (2024). Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease. Biomedicine & Pharmacotherapy. 173. 116399–116399. 12 indexed citations

Górecki, Lukáš, et al.. (2024). Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists. Biomedicine & Pharmacotherapy. 176. 116821–116821. 6 indexed citations

Múčková, Ľubica, Martina Hrabinová, Tereza Kobrlová, et al.. (2023). Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity. Archives of Toxicology. 97(8). 2209–2217. 9 indexed citations

Махаева, Галина Ф., N. V. Kovaleva, Natalia P. Boltneva, et al.. (2022). Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer’s Activity Profile. Molecules. 27(3). 1060–1060. 19 indexed citations

Chrienová, Žofia, Eugenie Nepovimová, Rudolf Andrýs, et al.. (2022). Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2605–2620. 9 indexed citations

Zhou, Yitian, Ainoleena Turku, Tuuli Jürgenson, et al.. (2021). Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine. Science Advances. 7(36). eabi6856–eabi6856. 19 indexed citations

Kaniaková, Martina, Jan Korábečný, Kristína Holubová, et al.. (2021). 7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo. Biochemical Pharmacology. 186. 114460–114460. 10 indexed citations

Górecki, Lukáš, Elisa Uliassi, Manuela Bartolini, et al.. (2021). Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. ACS Chemical Neuroscience. 12(9). 1698–1715. 19 indexed citations

10.

Górecki, Lukáš, Jiřı́ Damborský, Rafael Doležal, et al.. (2021). Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors. European Journal of Medicinal Chemistry. 219. 113434–113434. 10 indexed citations

11.

Mezeiová, Eva, Jana Janočková, Rudolf Andrýs, et al.. (2020). 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 211. 113112–113112. 25 indexed citations

12.

Singh, Namrata, Eugenie Nepovimová, Jan Korábečný, et al.. (2019). Interaction of synthesized nitrogen enriched graphene quantum dots with novel anti-Alzheimer’s drugs: spectroscopic insights. Journal of Biomolecular Structure and Dynamics. 38(6). 1–16. 18 indexed citations

13.

Górecki, Lukáš, Rudolf Andrýs, Monika Schmidt, et al.. (2019). Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors. ACS Medicinal Chemistry Letters. 11(1). 65–71. 13 indexed citations

14.

Korábečný, Jan. (2018). Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders. Česká a slovenská farmacie. 67(2). 51–58. 1 indexed citations

15.

Więckowska, Anna, Tomasz Wichur, Justyna Godyń, et al.. (2018). Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. ACS Chemical Neuroscience. 9(5). 1195–1214. 44 indexed citations

16.

Panek, Dawid, Anna Więckowska, Jakub Jończyk, et al.. (2018). Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. ACS Chemical Neuroscience. 9(5). 1074–1094. 49 indexed citations

17.

Kuča, Kamil, Kamil Musílek, Daniel Jun, et al.. (2018). Oxime K074 – in vitro and in silico reactivation of acetylcholinesterase inhibited by nerve agents and pesticides. Toxin Reviews. 39(2). 157–166. 5 indexed citations

18.

Mezeiová, Eva, Katarína Špilovská, Eugenie Nepovimová, et al.. (2018). Profiling donepezil template into multipotent hybrids with antioxidant properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 583–606. 56 indexed citations

19.

Šepsová, Vendula, Jana Žďárová Karasová, G. Tobin, et al.. (2015). Cholinergic properties of new 7-methoxytacrine-donepezil derivatives. General Physiology and Biophysics. 34(2). 189–200. 17 indexed citations

20.

Zemek, Filip, Lucie Drtinová, Eugenie Nepovimová, et al.. (2014). Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opinion on Drug Safety. 13(6). 759–774. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact